Prescription drug · NDA
Cerianna (Fluoroestradiol f 18) NDC 72874-001
Fluoroestradiol f-18 100 mCi/mL · Injection · Intravenous · GE Healthcare Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72874-001-01 | 72874000101 | 50 mL in 1 VIAL, MULTI-DOSE (72874-001-01)Marketed from May 20, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cerianna
- Generic name (nonproprietary)
- fluoroestradiol f 18
- Active ingredients
- Fluoroestradiol f-18 — 100 mCi/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- GE Healthcare Inc.NDC labeler code 72874
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 212155
- Marketing start
- Listing expires
- Other FDA classes
- Positron Emitting Activity (Mechanism)
- Identifiers
- Product ID 72874-001_fd28ffaf-5b17-43e7-bc91-fd623819340eSPL ID fd28ffaf-5b17-43e7-bc91-fd623819340eSPL set ID b2c2a2df-cf3e-4a29-a033-231ed5a94b58UNII T32277KB09
- Pharmacologic class
- Radioactive Diagnostic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472874000101followed by a unit qualifier and the quantityPackage 72874-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
CERIANNA is indicated for use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer. CERIANNA is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer. ( 1 ) Limitations of Use Tissue biopsy should be used to confirm recurrence of breast cancer and to verify ER status by pathology. CERIANNA is not useful for imaging other receptors, such as human epidermal growth factor receptor 2…
Excerpt only. Read the full label for complete information.
About NDC 72874-001
- What is NDC 72874-001?
- 72874-001 is the product NDC for Cerianna (fluoroestradiol f 18), Fluoroestradiol f-18 100 mCi/mL injection, listed with the FDA by GE Healthcare Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cerianna (Fluoroestradiol f 18).
- What is the active ingredient?
- Fluoroestradiol f-18.
- Who is the labeler?
- GE Healthcare Inc., NDC labeler code 72874. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cerianna?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.